
|Articles|April 27, 2023
Talking Automation in Fill/Finish and Cell & Gene Therapies with James Rorke (INTERPHEX 2023)
James Rorke, vice-president, operations, Steriline North America, discusses the benefits of automation in fill/finish operations.
Advertisement
James Rorke, vice-president, operations, Steriline North America, discusses the advantages of automation in fill/finish, particulary for low volume, high quaility products such as cell and gene therapies, for which minimizing product loss is crucial.
For more INTERPHEX 2023 video content, check
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Weekly News Roundup—Week of Oct. 13, 2025
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
4
Futureproofing Viral Safety: Global Perspectives from an Educator, Supplier, and Biosafety Expert
5